Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy

被引:50
作者
Fan, Yue-Zu [1 ]
Sun, Wei [1 ]
机构
[1] Tongji Univ, Tongji Hosp, Sch Med, Dept Surg, Shanghai 200065, Peoples R China
关键词
Tumor-target therapy; Signaling pathways; High aggressive tumor; Molecular regulation; Prognosis; Vasculogenic mimicry;
D O I
10.4240/wjgs.v2.i4.117
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Vasculogenic mimicry (VM), is a term that describes the unique ability of highly aggressive tumor cells to express a multipotent, stem cell-like phenotype, and form a pattern of vasculogenic-like networks in three-dimensional culture. As an angiogenesis-independent pathway, VM and/ or periodic acid-schiff-positive patterns are associated with poor prognosis in tumor patients. Moreover, VM is resistant to angiogenesis inhibitors. Here, we will review the advances in research on biochemical and molecular signaling pathways of VM in tumors and on potential anti-VM therapy strategy. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:117 / 127
页数:11
相关论文
共 112 条
[1]   Tissue factor expression and angiogenesis in human prostate carcinoma [J].
Abdulkadir, SA ;
Carvalhal, GF ;
Kaleem, Z ;
Kisiel, W ;
Humphrey, PA ;
Catalona, WJ ;
Milbrandt, J .
HUMAN PATHOLOGY, 2000, 31 (04) :443-447
[2]  
Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603
[3]   A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells [J].
Basu, Gargi D. ;
Liang, Winnie S. ;
Stephan, Dietrich A. ;
Wegener, Lee T. ;
Conley, Christopher R. ;
Pockaj, Barbara A. ;
Mukherjee, Pinku .
BREAST CANCER RESEARCH, 2006, 8 (06)
[4]   Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells [J].
Basu, GD ;
Pathangey, LB ;
Tinder, TL ;
Gendler, SJ ;
Mukherjee, P .
BREAST CANCER RESEARCH, 2005, 7 (04) :R422-R435
[5]   Role of Id proteins in embryonic and tumor angiogenesis [J].
Benezra, R .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (06) :237-241
[6]   Molecular classification of cutaneous malignant melanoma by gene expression profiling [J].
Bittner, M ;
Meitzer, P ;
Chen, Y ;
Jiang, Y ;
Seftor, E ;
Hendrix, M ;
Radmacher, M ;
Simon, R ;
Yakhini, Z ;
Ben-Dor, A ;
Sampas, N ;
Dougherty, E ;
Wang, E ;
Marincola, F ;
Gooden, C ;
Lueders, J ;
Glatfelter, A ;
Pollock, P ;
Carpten, J ;
Gillanders, E ;
Leja, D ;
Dietrich, K ;
Beaudry, C ;
Berens, M ;
Alberts, D ;
Sondak, V ;
Hayward, N ;
Trent, J .
NATURE, 2000, 406 (6795) :536-540
[7]   ETV6: A versatile player in leukemogenesis [J].
Bohlander, SK .
SEMINARS IN CANCER BIOLOGY, 2005, 15 (03) :162-174
[8]   Epac proteins: multi-purpose cAMP targets [J].
Bos, Johannes L. .
TRENDS IN BIOCHEMICAL SCIENCES, 2006, 31 (12) :680-686
[9]   Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo [J].
Brantley, DM ;
Cheng, N ;
Thompson, EJ ;
Lin, Q ;
Brekken, RA ;
Thorpe, PE ;
Muraoka, RS ;
Cerretti, DP ;
Pozzi, A ;
Jackson, D ;
Lin, C ;
Chen, J .
ONCOGENE, 2002, 21 (46) :7011-7026
[10]  
Cai XS, 2004, CHINESE MED J-PEKING, V117, P94